Avadel Pharmaceuticals (AVDL) PT Raised to $14 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts AVDL Hot Sheet
Price: $21.64 --0%
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Join SI Premium – FREE
H.C. Wainwright analyst Oren Livnat raised the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $14.00 (from $13.00) while maintaining a Buy rating.
You May Also Be Interested In
- Canaccord Downgrades Botanix Pharmaceuticals Ltd (BOT:AU) to Hold
- Royal Caribbean Cruises (RCL) PT Raised to $350 at Jefferies
- Corning (GLW) PT Lowered to $175 at Truist Securities, 'We would use the recent pull back as a buying opportunity'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
